Unlocking market access in Europe: Advantages of localized oral solid dose (OSD) production

How can biotech or pharma organizations succeed in the complex European market? Partnering with a local OSD production facility offering expertise in regulatory considerations, technical and commercial capabilities, and a robust supply chain strategy can be the defining factor in gaining and maintaining a foothold.

Learn more, with insights from Pharma Ignite and Thermo Fisher Scientific.

Read now to understand:

How a deep understanding of evolving European regulatory requirements can play a critical role in OSD development
Why a strategically located facility like Thermo Fisher’s Bourgoin site can ensure supply chain stability
How a local site like the one in Bourgoin can effortlessly respond to market fluctuations with scale-up or scale-down production capabilities
Why access to specialized knowledge in OSD product development and manufacturing is so critical

Read the fact sheet

Your Company Email Address

Opt In?

By completing this form You agree Thermo Fisher Scientific Inc and Citeline. may contact you directly about industry news, products, services and events that may be of interest to you subject to the privacy policies of Thermo Fisher Scientific Inc and Citeline privacy policy.